M&A expected to rise but cash issues will continue to haunt
This article was originally published in Scrip
Executive Summary
Life science executives expect deal activity to recover this year with an increase in mergers and acquisitions, a survey by the consultancy group Ernst & Young has found. However, the lingering effects of economic crisis will continue to hamper the availability of capital in the sector.